Toward New Biomarkers of Cardiometabolic Diseases

Cardiometabolic diseases can be present long before becoming clinically apparent. Accurate predictors of disease are of particular importance since the delay or prevention of morbidity is possible via pharmacological and behavioral interventions. Metabolomics is increasingly applied to biomarker dis...

Full description

Saved in:
Bibliographic Details
Published in:Cell metabolism 2013-07, Vol.18 (1), p.43-50
Main Authors: Roberts, Lee D., Gerszten, Robert E.
Format: Article
Language:English
Subjects:
Animals
Biomarkers - metabolism
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - metabolism
Disease Models, Animal
Gene Expression Profiling
Humans
Metabolic Diseases - diagnosis
Metabolic Diseases - epidemiology
Metabolic Diseases - metabolism
Metabolomics
Predictive Value of Tests
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiometabolic diseases can be present long before becoming clinically apparent. Accurate predictors of disease are of particular importance since the delay or prevention of morbidity is possible via pharmacological and behavioral interventions. Metabolomics is increasingly applied to biomarker discovery. Understanding how metabolites relate with established cardiometabolic risk factors is critical in evaluating their potential value as clinical biomarkers. Large epidemiological cohort studies can assess whether metabolite biomarkers improve upon existing disease markers. Furthermore, experimental work in model systems and integration with other functional genomic approaches will facilitate the discovery of causal links between select biomarkers and disease pathogenesis.
ISSN:1550-4131
1932-7420
DOI:10.1016/j.cmet.2013.05.009